GO:0022627 | cytosolic small ribosomal subunit | 2.39e-13 | 3.44e-09 | 7.531 | 6 | 20 | 39 |
GO:0015935 | small ribosomal subunit | 9.38e-13 | 1.35e-08 | 8.466 | 5 | 9 | 17 |
GO:0019083 | viral transcription | 2.34e-11 | 3.37e-07 | 6.476 | 6 | 20 | 81 |
GO:0006415 | translational termination | 3.63e-11 | 5.23e-07 | 6.373 | 6 | 20 | 87 |
GO:0006414 | translational elongation | 5.47e-11 | 7.88e-07 | 6.277 | 6 | 20 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.08e-10 | 1.56e-06 | 6.116 | 6 | 20 | 104 |
GO:0030126 | COPI vesicle coat | 1.35e-10 | 1.95e-06 | 8.646 | 4 | 7 | 12 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.90e-10 | 2.74e-06 | 5.983 | 6 | 20 | 114 |
GO:0048205 | COPI coating of Golgi vesicle | 1.96e-10 | 2.82e-06 | 8.531 | 4 | 8 | 13 |
GO:0019058 | viral life cycle | 2.00e-10 | 2.89e-06 | 5.971 | 6 | 23 | 115 |
GO:0006413 | translational initiation | 4.42e-10 | 6.38e-06 | 5.783 | 6 | 21 | 131 |
GO:0003735 | structural constituent of ribosome | 5.80e-10 | 8.37e-06 | 5.718 | 6 | 22 | 137 |
GO:0005829 | cytosol | 7.06e-10 | 1.02e-05 | 2.531 | 12 | 61 | 2496 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.44e-09 | 4.96e-05 | 7.587 | 4 | 8 | 25 |
GO:0016071 | mRNA metabolic process | 1.09e-08 | 1.58e-04 | 5.015 | 6 | 25 | 223 |
GO:0006412 | translation | 1.31e-08 | 1.90e-04 | 4.971 | 6 | 23 | 230 |
GO:0016070 | RNA metabolic process | 2.01e-08 | 2.90e-04 | 4.868 | 6 | 25 | 247 |
GO:0061024 | membrane organization | 7.17e-08 | 1.03e-03 | 5.373 | 5 | 12 | 145 |
GO:0016020 | membrane | 6.16e-07 | 8.88e-03 | 2.686 | 9 | 41 | 1681 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 6.72e-07 | 9.69e-03 | 7.357 | 3 | 3 | 22 |
GO:0044267 | cellular protein metabolic process | 9.53e-07 | 1.37e-02 | 3.927 | 6 | 23 | 474 |
GO:0016032 | viral process | 1.91e-06 | 2.76e-02 | 3.755 | 6 | 33 | 534 |
GO:0044822 | poly(A) RNA binding | 6.32e-06 | 9.11e-02 | 2.994 | 7 | 32 | 1056 |
GO:0010467 | gene expression | 7.08e-06 | 1.02e-01 | 3.430 | 6 | 29 | 669 |
GO:0006886 | intracellular protein transport | 8.77e-06 | 1.26e-01 | 4.813 | 4 | 7 | 171 |
GO:0042274 | ribosomal small subunit biogenesis | 4.17e-05 | 6.01e-01 | 7.646 | 2 | 6 | 12 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 8.57e-05 | 1.00e+00 | 7.144 | 2 | 4 | 17 |
GO:0030529 | ribonucleoprotein complex | 9.53e-05 | 1.00e+00 | 5.009 | 3 | 7 | 112 |
GO:0005844 | polysome | 1.59e-04 | 1.00e+00 | 6.708 | 2 | 2 | 23 |
GO:0019843 | rRNA binding | 2.20e-04 | 1.00e+00 | 6.476 | 2 | 4 | 27 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.94e-04 | 1.00e+00 | 6.061 | 2 | 3 | 36 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0005840 | ribosome | 1.02e-03 | 1.00e+00 | 5.373 | 2 | 8 | 58 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0051683 | establishment of Golgi localization | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 2 | 3 |
GO:0034191 | apolipoprotein A-I receptor binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0006364 | rRNA processing | 2.66e-03 | 1.00e+00 | 4.677 | 2 | 7 | 94 |
GO:0005925 | focal adhesion | 3.01e-03 | 1.00e+00 | 3.300 | 3 | 19 | 366 |
GO:0060684 | epithelial-mesenchymal cell signaling | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 4 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 3.95e-03 | 1.00e+00 | 4.386 | 2 | 4 | 115 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 5 |
GO:0033119 | negative regulation of RNA splicing | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 5 |
GO:0036336 | dendritic cell migration | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0060789 | hair follicle placode formation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0007097 | nuclear migration | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0003334 | keratinocyte development | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0045182 | translation regulator activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0030157 | pancreatic juice secretion | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0000028 | ribosomal small subunit assembly | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 3 | 7 |
GO:0034101 | erythrocyte homeostasis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0051489 | regulation of filopodium assembly | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0000082 | G1/S transition of mitotic cell cycle | 6.54e-03 | 1.00e+00 | 4.012 | 2 | 9 | 149 |
GO:0005198 | structural molecule activity | 6.62e-03 | 1.00e+00 | 4.002 | 2 | 6 | 150 |
GO:0090136 | epithelial cell-cell adhesion | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 9 |
GO:0070062 | extracellular vesicular exosome | 7.84e-03 | 1.00e+00 | 1.587 | 6 | 40 | 2400 |
GO:0031274 | positive regulation of pseudopodium assembly | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 10 |
GO:0060047 | heart contraction | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 10 |
GO:0019082 | viral protein processing | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 12 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.03e-02 | 1.00e+00 | 3.669 | 2 | 4 | 189 |
GO:0031929 | TOR signaling | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 13 |
GO:0032479 | regulation of type I interferon production | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 2 | 13 |
GO:0031333 | negative regulation of protein complex assembly | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0030131 | clathrin adaptor complex | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 14 |
GO:0031369 | translation initiation factor binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 15 |
GO:0048821 | erythrocyte development | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 15 |
GO:0030225 | macrophage differentiation | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 15 |
GO:0042176 | regulation of protein catabolic process | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 16 |
GO:0030675 | Rac GTPase activator activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 16 |
GO:0075733 | intracellular transport of virus | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 3 | 17 |
GO:0030742 | GTP-dependent protein binding | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 17 |
GO:0019068 | virion assembly | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 2 | 17 |
GO:0090316 | positive regulation of intracellular protein transport | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 17 |
GO:0007088 | regulation of mitosis | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 18 |
GO:0046847 | filopodium assembly | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0007369 | gastrulation | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0043473 | pigmentation | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 20 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 21 |
GO:0031424 | keratinization | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0005737 | cytoplasm | 1.82e-02 | 1.00e+00 | 1.159 | 7 | 43 | 3767 |
GO:0007220 | Notch receptor processing | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 2 | 22 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 1 | 23 |
GO:0002040 | sprouting angiogenesis | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 1 | 23 |
GO:0007163 | establishment or maintenance of cell polarity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 24 |
GO:0043065 | positive regulation of apoptotic process | 2.01e-02 | 1.00e+00 | 3.165 | 2 | 6 | 268 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 2 | 25 |
GO:0005978 | glycogen biosynthetic process | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 26 |
GO:0045859 | regulation of protein kinase activity | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 26 |
GO:0007264 | small GTPase mediated signal transduction | 2.17e-02 | 1.00e+00 | 3.107 | 2 | 7 | 279 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 27 |
GO:0032467 | positive regulation of cytokinesis | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 27 |
GO:0072686 | mitotic spindle | 2.39e-02 | 1.00e+00 | 5.373 | 1 | 1 | 29 |
GO:0031647 | regulation of protein stability | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 30 |
GO:0001890 | placenta development | 2.55e-02 | 1.00e+00 | 5.277 | 1 | 1 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 2.55e-02 | 1.00e+00 | 5.277 | 1 | 1 | 31 |
GO:0032480 | negative regulation of type I interferon production | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 32 |
GO:0033077 | T cell differentiation in thymus | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 33 |
GO:0019901 | protein kinase binding | 2.75e-02 | 1.00e+00 | 2.923 | 2 | 6 | 317 |
GO:0042692 | muscle cell differentiation | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 34 |
GO:0032855 | positive regulation of Rac GTPase activity | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 1 | 35 |
GO:0034332 | adherens junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 36 |
GO:0045740 | positive regulation of DNA replication | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 1 | 36 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 3.36e-02 | 1.00e+00 | 4.874 | 1 | 3 | 41 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 3.52e-02 | 1.00e+00 | 4.805 | 1 | 2 | 43 |
GO:0021762 | substantia nigra development | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 2 | 44 |
GO:0045727 | positive regulation of translation | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 1 | 44 |
GO:0008344 | adult locomotory behavior | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 1 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 2 | 46 |
GO:0044297 | cell body | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 1 | 46 |
GO:0008284 | positive regulation of cell proliferation | 3.87e-02 | 1.00e+00 | 2.654 | 2 | 7 | 382 |
GO:0005730 | nucleolus | 3.91e-02 | 1.00e+00 | 1.551 | 4 | 24 | 1641 |
GO:0007030 | Golgi organization | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 2 | 49 |
GO:0007254 | JNK cascade | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 3 | 49 |
GO:0030175 | filopodium | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 2 | 50 |
GO:0030666 | endocytic vesicle membrane | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 2 | 53 |
GO:0051403 | stress-activated MAPK cascade | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 3 | 54 |
GO:0046330 | positive regulation of JNK cascade | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 1 | 55 |
GO:0016197 | endosomal transport | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 3 | 57 |
GO:0043066 | negative regulation of apoptotic process | 4.68e-02 | 1.00e+00 | 2.503 | 2 | 13 | 424 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 4.80e-02 | 1.00e+00 | 4.348 | 1 | 1 | 59 |
GO:0032481 | positive regulation of type I interferon production | 4.96e-02 | 1.00e+00 | 4.300 | 1 | 3 | 61 |
GO:0035091 | phosphatidylinositol binding | 4.96e-02 | 1.00e+00 | 4.300 | 1 | 1 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 4.96e-02 | 1.00e+00 | 4.300 | 1 | 2 | 61 |
GO:0030141 | secretory granule | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 1 | 62 |
GO:0006417 | regulation of translation | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 62 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 6 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 4 | 65 |
GO:0031295 | T cell costimulation | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 3 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 4 | 65 |
GO:0035264 | multicellular organism growth | 5.44e-02 | 1.00e+00 | 4.165 | 1 | 1 | 67 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.67e-02 | 1.00e+00 | 4.102 | 1 | 8 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 5.75e-02 | 1.00e+00 | 4.081 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 5.75e-02 | 1.00e+00 | 4.081 | 1 | 4 | 71 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 6 | 72 |
GO:0003729 | mRNA binding | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 2 | 72 |
GO:0034162 | toll-like receptor 9 signaling pathway | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 4 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.91e-02 | 1.00e+00 | 4.041 | 1 | 4 | 73 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 2 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 8 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 6 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 1 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 6.15e-02 | 1.00e+00 | 3.983 | 1 | 4 | 76 |
GO:0010629 | negative regulation of gene expression | 6.22e-02 | 1.00e+00 | 3.964 | 1 | 2 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 4 | 78 |
GO:0005179 | hormone activity | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 1 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 8 | 79 |
GO:0034138 | toll-like receptor 3 signaling pathway | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 4 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 4 | 80 |
GO:0045177 | apical part of cell | 6.54e-02 | 1.00e+00 | 3.891 | 1 | 1 | 81 |
GO:0050852 | T cell receptor signaling pathway | 6.85e-02 | 1.00e+00 | 3.822 | 1 | 2 | 85 |
GO:0042593 | glucose homeostasis | 7.01e-02 | 1.00e+00 | 3.788 | 1 | 1 | 87 |
GO:0000187 | activation of MAPK activity | 7.24e-02 | 1.00e+00 | 3.739 | 1 | 2 | 90 |
GO:0071456 | cellular response to hypoxia | 7.39e-02 | 1.00e+00 | 3.708 | 1 | 3 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7.39e-02 | 1.00e+00 | 3.708 | 1 | 6 | 92 |
GO:0034142 | toll-like receptor 4 signaling pathway | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 4 | 96 |
GO:0045087 | innate immune response | 8.56e-02 | 1.00e+00 | 2.012 | 2 | 8 | 596 |
GO:0030496 | midbody | 8.63e-02 | 1.00e+00 | 3.476 | 1 | 2 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 8.70e-02 | 1.00e+00 | 3.463 | 1 | 4 | 109 |
GO:0005815 | microtubule organizing center | 8.70e-02 | 1.00e+00 | 3.463 | 1 | 3 | 109 |
GO:0097190 | apoptotic signaling pathway | 9.01e-02 | 1.00e+00 | 3.411 | 1 | 3 | 113 |
GO:0000209 | protein polyubiquitination | 9.24e-02 | 1.00e+00 | 3.373 | 1 | 7 | 116 |
GO:0006006 | glucose metabolic process | 9.39e-02 | 1.00e+00 | 3.348 | 1 | 3 | 118 |
GO:0007219 | Notch signaling pathway | 9.54e-02 | 1.00e+00 | 3.324 | 1 | 3 | 120 |
GO:0030036 | actin cytoskeleton organization | 9.77e-02 | 1.00e+00 | 3.289 | 1 | 2 | 123 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 9.85e-02 | 1.00e+00 | 3.277 | 1 | 3 | 124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.01e-01 | 1.00e+00 | 3.231 | 1 | 3 | 128 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.08e-01 | 1.00e+00 | 3.144 | 1 | 5 | 136 |
GO:0005911 | cell-cell junction | 1.08e-01 | 1.00e+00 | 3.144 | 1 | 2 | 136 |
GO:0008286 | insulin receptor signaling pathway | 1.12e-01 | 1.00e+00 | 3.081 | 1 | 3 | 142 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.14e-01 | 1.00e+00 | 3.051 | 1 | 3 | 145 |
GO:0010628 | positive regulation of gene expression | 1.15e-01 | 1.00e+00 | 3.041 | 1 | 4 | 146 |
GO:0034220 | ion transmembrane transport | 1.17e-01 | 1.00e+00 | 3.012 | 1 | 2 | 149 |
GO:0042981 | regulation of apoptotic process | 1.18e-01 | 1.00e+00 | 3.002 | 1 | 7 | 150 |
GO:0010008 | endosome membrane | 1.19e-01 | 1.00e+00 | 2.993 | 1 | 5 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.22e-01 | 1.00e+00 | 2.946 | 1 | 3 | 156 |
GO:0043005 | neuron projection | 1.23e-01 | 1.00e+00 | 2.937 | 1 | 6 | 157 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.31e-01 | 1.00e+00 | 2.839 | 1 | 3 | 168 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.43e-01 | 1.00e+00 | 2.708 | 1 | 3 | 184 |
GO:0003924 | GTPase activity | 1.52e-01 | 1.00e+00 | 2.609 | 1 | 7 | 197 |
GO:0006184 | GTP catabolic process | 1.64e-01 | 1.00e+00 | 2.490 | 1 | 7 | 214 |
GO:0019221 | cytokine-mediated signaling pathway | 1.69e-01 | 1.00e+00 | 2.443 | 1 | 2 | 221 |
GO:0007067 | mitotic nuclear division | 1.73e-01 | 1.00e+00 | 2.405 | 1 | 5 | 227 |
GO:0030425 | dendrite | 1.75e-01 | 1.00e+00 | 2.386 | 1 | 2 | 230 |
GO:0043025 | neuronal cell body | 1.86e-01 | 1.00e+00 | 2.294 | 1 | 4 | 245 |
GO:0005975 | carbohydrate metabolic process | 1.91e-01 | 1.00e+00 | 2.248 | 1 | 3 | 253 |
GO:0000166 | nucleotide binding | 1.95e-01 | 1.00e+00 | 2.214 | 1 | 2 | 259 |
GO:0006281 | DNA repair | 1.97e-01 | 1.00e+00 | 2.203 | 1 | 4 | 261 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.02e-01 | 1.00e+00 | 2.160 | 1 | 4 | 269 |
GO:0005525 | GTP binding | 2.30e-01 | 1.00e+00 | 1.955 | 1 | 7 | 310 |
GO:0007275 | multicellular organismal development | 2.34e-01 | 1.00e+00 | 1.927 | 1 | 1 | 316 |
GO:0043231 | intracellular membrane-bounded organelle | 2.35e-01 | 1.00e+00 | 1.918 | 1 | 5 | 318 |
GO:0007411 | axon guidance | 2.35e-01 | 1.00e+00 | 1.914 | 1 | 3 | 319 |
GO:0015031 | protein transport | 2.50e-01 | 1.00e+00 | 1.817 | 1 | 8 | 341 |
GO:0000139 | Golgi membrane | 2.62e-01 | 1.00e+00 | 1.735 | 1 | 6 | 361 |
GO:0000278 | mitotic cell cycle | 2.81e-01 | 1.00e+00 | 1.620 | 1 | 11 | 391 |
GO:0055085 | transmembrane transport | 3.08e-01 | 1.00e+00 | 1.466 | 1 | 3 | 435 |
GO:0007596 | blood coagulation | 3.19e-01 | 1.00e+00 | 1.401 | 1 | 3 | 455 |
GO:0042802 | identical protein binding | 3.36e-01 | 1.00e+00 | 1.312 | 1 | 3 | 484 |
GO:0048471 | perinuclear region of cytoplasm | 3.46e-01 | 1.00e+00 | 1.260 | 1 | 7 | 502 |
GO:0005886 | plasma membrane | 3.67e-01 | 1.00e+00 | 0.482 | 3 | 20 | 2582 |
GO:0006915 | apoptotic process | 3.76e-01 | 1.00e+00 | 1.115 | 1 | 9 | 555 |
GO:0005783 | endoplasmic reticulum | 3.76e-01 | 1.00e+00 | 1.112 | 1 | 3 | 556 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.84e-01 | 1.00e+00 | 1.076 | 1 | 7 | 570 |
GO:0005794 | Golgi apparatus | 4.05e-01 | 1.00e+00 | 0.978 | 1 | 9 | 610 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.91e-01 | 1.00e+00 | 0.607 | 1 | 6 | 789 |
GO:0005615 | extracellular space | 5.61e-01 | 1.00e+00 | 0.329 | 1 | 2 | 957 |
GO:0005654 | nucleoplasm | 6.08e-01 | 1.00e+00 | 0.152 | 1 | 15 | 1082 |
GO:0005515 | protein binding | 6.11e-01 | 1.00e+00 | -0.003 | 5 | 62 | 6024 |
GO:0044281 | small molecule metabolic process | 6.51e-01 | 1.00e+00 | -0.011 | 1 | 15 | 1211 |
GO:0046872 | metal ion binding | 6.80e-01 | 1.00e+00 | -0.121 | 1 | 10 | 1307 |
GO:0006351 | transcription, DNA-templated | 7.19e-01 | 1.00e+00 | -0.267 | 1 | 6 | 1446 |
GO:0005634 | nucleus | 7.84e-01 | 1.00e+00 | -0.338 | 3 | 43 | 4559 |